當(dāng)前位置：首頁 SCI期刊 SCIE期刊醫(yī)學(xué) 中科院3區(qū) JCRQ2 期刊介紹(非官網(wǎng))

Clinica Chimica ActaSCIE

國際簡稱：CLIN CHIM ACTA 參考譯名：Acta 化學(xué)診所

中科院分區(qū)
3區(qū)
CiteScore分區(qū)
Q1
JCR分區(qū)
Q2

基本信息：: ISSN：0009-8981; E-ISSN：1873-3492; 是否OA：未開放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：NETHERLANDS; 出版商：Elsevier; 出版語言：English; 出版周期：Monthly; 出版年份：1956; 研究方向：醫(yī)學(xué)-醫(yī)學(xué)實(shí)驗(yàn)技術(shù)

評價(jià)信息：: 影響因子：3.2; H-index：127; CiteScore指數(shù)：10.1; SJR指數(shù)：1.016; SNIP指數(shù)：1.086

發(fā)文數(shù)據(jù)：: Gold OA文章占比：16.95%; 研究類文章占比：91.13%; 年發(fā)文量：327; 自引率：0.02; 開源占比：0.0813; 出版撤稿占比：0; 出版國人文章占比：0.19; OA被引用占比：0.0316...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Clinica Chimica Acta期刊介紹

The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)

Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.

The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.

期刊簡介Clinica Chimica Acta期刊介紹

《Clinica Chimica Acta》自1956出版以來，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺(tái)，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間：約3.0個(gè)月約5.2周
醫(yī)學(xué)
MEDICAL LABORATORY TECHNOLOGY
SCIE
中科院3區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Clinica Chimica Acta Cite Score數(shù)據(jù)

CiteScore：10.1
SJR：1.016
SNIP：1.086

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Biochemistry (medical)	Q1	10 / 72	86%
大類：Medicine 小類：Biochemistry	Q1	60 / 438	86%
大類：Medicine 小類：Clinical Biochemistry	Q1	18 / 117	85%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ)，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評價(jià)期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標(biāo)來評價(jià)。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Clinica Chimica Acta 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	3區(qū)	MEDICAL LABORATORY TECHNOLOGY 醫(yī)學(xué)實(shí)驗(yàn)技術(shù)	3區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對國際、國內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級劃分的期刊評價(jià)標(biāo)準(zhǔn)。它為我國科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評價(jià)國際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類似于“優(yōu)、良、及格”等。最開始，這個(gè)分區(qū)只是為了方便圖書管理及圖書情報(bào)領(lǐng)域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Clinica Chimica Acta JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：MEDICAL LABORATORY TECHNOLOGY	SCIE	Q2	9 / 30	71.7%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：MEDICAL LABORATORY TECHNOLOGY	SCIE	Q1	7 / 30	78.33%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評價(jià)期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計(jì)

國家/地區(qū)數(shù)量
CHINA MAINLAND660
Spain570
USA256
Italy215
GERMANY (FED REP GER)116
Belgium112
Japan104
France101
England87
India78

本刊中國學(xué)者近年發(fā)表論文

1、A rapid multiplex assay of human malaria parasites by digital PCR
Author: Dong, Liu; Li, Weijia; Xu, Qianqian; Gu, Jianfei; Kang, Zhihua; Chen, Jian; Xu, Xiao; Zhang, Xinju; Zhang, Xiuming; Jiang, Haoqin; Guan, Ming

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 70-78. DOI: 10.1016/j.cca.2022.12.001
2、The value of lipid metabolites 9,10-DOA and 11,12-EET in prenatal diagnosis of fetal heart defects
Author: Fang, Yiwei; Zhang, Zheng; Zhao, Yun; Sun, Guoqiang; Peng, Meilin; Liu, Chunyan; Yi, Guilin; Zhao, Kai; Yang, Hui

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 544, Issue , pp. -. DOI: 10.1016/j.cca.2023.117330
3、Biomarkers for chemotherapy and drug resistance in the mismatch repair pathway
Author: Dong, Liu; Jiang, Haoqin; Kang, Zhihua; Guan, Ming

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 544, Issue , pp. -. DOI: 10.1016/j.cca.2023.117338
4、Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy
Author: Huang, Ziyue; Wang, Zhensheng; Xia, Haoming; Ge, Ziqiang; Yu, Liang; Li, Jiehan; Bao, Haolin; Liang, Zixin; Cui, Yunfu; Xu, Yi

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 162-169. DOI: 10.1016/j.cca.2022.12.010
5、Diagnostic potential of site-specific serotransferrin N-glycosylation in discriminating different liver diseases
Author: Zhang, Jiyun; Lai, Zhizhen; Ding, Rui; Zhou, Jinyu; Yuan, Zhonghao; Li, Dan; Qin, Xuzhen; Zhou, Jiang; li, Zhili

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 175-183. DOI: 10.1016/j.cca.2022.12.015
6、Fibrinogen beta chain may be a potential predict biomarker for pre-eclampsia: A preliminary study
Author: Shi, Junzhu; Zeng, Shanshui; Zhang, Yonggang; Zuo, Zhihua; Tan, Xiaoyu

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 206-214. DOI: 10.1016/j.cca.2022.12.012
7、Evaluating the value of anti-SARS-CoV-2 antibody detection and neutralizing responses with euvirus: A population of 10776 close contacts in the epidemic of Fujian
Author: Zeng, Yongbin; Lin, Caorui; Liu, Can; Huang, Chun; Chen, Falin; Cao, Yingping; Wu, Siying; Wei, Donghong; Lin, Zhong; Zhang, Yali; Zhang, Ling; Teng, Jing; Li, Zishun; Hong, Guolin; Yang, Tianci; Ye, Huiming; Tu, Haijian; Xiao, Yupeng; Huang, Lishan; Zhang, Jiawei; Chen, Tianbin; Li, Jinming; Ji, Fusui; Ou, Qishui

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 237-243. DOI: 10.1016/j.cca.2022.12.017
8、Intrafollicular fluid metabolic abnormalities in relation to ovarian hyperstimulation syndrome: Follicular fluid metabolomics via gas chromatography-mass spectrometry
Author: Sun, Yixuan; Hao, Lijuan; Han, Wei; Luo, Jing; Zheng, Jing; Yuan, Dong; Ye, Hong; Li, Qinke; Huang, Guoning; Han, Tingli; Yang, Zhu

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 538, Issue , pp. 189-202. DOI: 10.1016/j.cca.2022.11.033